Federal Register Notices > Notices of Application - 2005 > Noramco Inc. Notices of Application - 2005FR Doc 05-70 [Federal Register: January 4, 2005 (Volume 70, Number 2)] [Notices] [Page 392-393] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr04ja05-85] DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to 21 CFR 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 4, 2004, Noramco Inc., Division of Ortho-McNeil, Inc., 500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal and by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Dihydrocodeine (9120), a basic class of controlled substance listed in Schedule II. The company plans to manufacture the listed controlled substance in bulk for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative, Office [[Page 393]] of Liaison and Policy (ODLR) and must be filed no later than March 7, 2005. Dated: December 21, 2004. William J. Walker, [FR Doc. 05-70 Filed 1-3-05; 8:45 am] BILLING CODE 4410-09-P
Registration
Support
|